Pluri Inc. (PLUR) stock
PLURNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
$0.92−0.06 (-6.62%)
Close on Nov 18, 2026Market cap $11.30MP/E –Yield –
Pluri net income
Net income is the profit left for shareholders after every expense, interest and tax.
Pluri's net income for the twelve months ending Jun 30, 2026 was -$23.82M. For fiscal 2026 it was -$23.82M. The highest annual figure on record is -$7.45M in fiscal 2010.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$23.82M | – |
| FY2025 | Jun 30, 2025 | -$22.58M | – |
| FY2024 | Jun 30, 2024 | -$20.89M | – |
| FY2023 | Jun 30, 2023 | -$28.32M | – |
| FY2022 | Jun 30, 2022 | -$41.24M | – |
| FY2021 | Jun 30, 2021 | -$49.87M | – |
| FY2020 | Jun 30, 2020 | -$29.15M | – |
| FY2019 | Jun 30, 2019 | -$35.31M | – |
| FY2018 | Jun 30, 2018 | -$26.13M | – |
| FY2017 | Jun 30, 2017 | -$27.81M | – |
| FY2016 | Jun 30, 2016 | -$23.25M | – |
| FY2015 | Jun 30, 2015 | -$24.68M | – |
| FY2014 | Jun 30, 2014 | -$26.93M | – |
| FY2013 | Jun 30, 2013 | -$21.16M | – |
| FY2012 | Jun 30, 2012 | -$14.79M | – |
| FY2011 | Jun 30, 2011 | -$10.85M | – |
| FY2010 | Jun 30, 2010 | -$7.45M | – |
Quarterly net income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | -$5.88M | – |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -$5.55M | – |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | -$6.54M | – |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | -$5.85M | – |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -$7.60M | – |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | -$6.15M | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -$2.96M | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -$5.88M | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -$5.73M | – |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | -$5.29M | – |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -$4.91M | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | -$4.96M | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | -$6.46M | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -$7.62M | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -$8.12M | – |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | -$6.12M | – |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -$9.01M | – |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -$9.87M | – |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | -$10.94M | – |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | -$11.43M | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | -$14.57M | – |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -$14.25M | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | -$12.55M | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -$8.49M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | -$8.14M | – |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | -$7.51M | – |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | -$6.37M | – |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | -$7.14M | – |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | -$7.76M | – |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | -$10.08M | – |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | -$8.68M | – |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | -$8.79M | – |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | -$8.98M | – |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | -$1.53M | – |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | -$8.23M | – |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | -$7.39M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | -$7.02M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | -$7.86M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | -$6.61M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | -$6.32M | – |
See a number that looks wrong?